[["sample_registration.submitter_specimen_id",{"left":{"name":"submitter_specimen_id","valueType":"string","description":"Unique identifier of the specimen, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}},"diff":{"name":"submitter_specimen_id","valueType":"string","description":"Unique identifier of the specimen, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}}}],["sample_registration.submitter_sample_id",{"left":{"name":"submitter_sample_id","valueType":"string","description":"Unique identifier of the sample, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}},"diff":{"name":"submitter_sample_id","valueType":"string","description":"Unique identifier of the sample, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}}}],["primary_diagnosis.submitter_donor_id",{"left":{"name":"submitter_donor_id","valueType":"string","description":"Unique identifier of the donor, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}},"diff":{"name":"submitter_donor_id","valueType":"string","description":"Unique identifier of the donor, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}}}],["primary_diagnosis.age_at_diagnosis",{"left":{"name":"age_at_diagnosis","valueType":"integer","description":"Age that the donor was first diagnosed with cancer, in years.","restrictions":{"required":true},"meta":{"units":"years"}},"diff":{"name":"age_at_diagnosis","valueType":"integer","description":"Age that the donor was first diagnosed with cancer, in years.","restrictions":{"required":true},"meta":{"units":"years"}}}],["primary_diagnosis.cancer_type_code",{"left":{"name":"cancer_type_code","valueType":"string","description":"The code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2016/en#/) classification.","restrictions":{"required":true,"regex":"[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{0,1}$"}},"diff":{"name":"cancer_type_code","valueType":"string","description":"The code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2016/en#/) classification.","restrictions":{"required":true,"regex":"[A-Z]{1}[0-9]{2}.[0-9]{0,3}[A-Z]{0,1}$"}}}],["primary_diagnosis.tumour_staging_system",{"left":{"name":"tumour_staging_system","valueType":"string","description":"Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).","restrictions":{"required":true,"codeList":["Binet","Rai","FIGO","Ann Arbor","Murphy","Lugano","AJCC 8th Edition","AJCC 7th Edition","AJCC 6th Edition","AJCC 5th Edition","AJCC 4th Edition","AJCC 3rd Edition","AJCC 2nd Edition","AJCC 1st Edition"]}},"diff":{"name":"tumour_staging_system","valueType":"string","description":"Specify the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).","restrictions":{"required":true,"codeList":["Binet","Rai","FIGO","Ann Arbor","Murphy","Lugano","AJCC 8th Edition","AJCC 7th Edition","AJCC 6th Edition","AJCC 5th Edition","AJCC 4th Edition","AJCC 3rd Edition","AJCC 2nd Edition","AJCC 1st Edition"]}}}],["primary_diagnosis.clinical_stage_group",{"left":{"name":"clinical_stage_group","description":"Stage group of the tumour, as assigned by the reporting tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).","valueType":"string"},"diff":{"name":"clinical_stage_group","description":"Stage group of the tumour, as assigned by the reporting tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).","valueType":"string"}}],["primary_diagnosis.stage_suffix",{"left":{"name":"stage_suffix","description":"If necessary, use this field to add any applicable stage suffixes. Stage suffixes may apply to certain staging systems such as Ann Arbour staging system where the four stages are divided into 4 categories (A, B, X and E).","valueType":"string"},"diff":{"name":"stage_suffix","description":"If necessary, use this field to add any applicable stage suffixes. Stage suffixes may apply to certain staging systems such as Ann Arbour staging system where the four stages are divided into 4 categories (A, B, X and E).","valueType":"string"}}],["primary_diagnosis.clinical_t_category",{"left":{"name":"clinical_t_category","description":"The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"},"diff":{"name":"clinical_t_category","description":"The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"}}],["primary_diagnosis.clinical_n_category",{"left":{"name":"clinical_n_category","description":"The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"},"diff":{"name":"clinical_n_category","description":"The code to represent the stage of cancer defined by which is the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"}}],["primary_diagnosis.clinical_m_category",{"left":{"name":"clinical_m_category","description":"The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.","valueType":"string"},"diff":{"name":"clinical_m_category","description":"The code to represent the stage of cancer defined bythe extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.","valueType":"string"}}],["primary_diagnosis.number_lymph_nodes_examined",{"left":{"name":"number_lymph_nodes_examined","description":"The total number of lymph nodes tested for the presence of cancer.","valueType":"integer"},"diff":{"name":"number_lymph_nodes_examined","description":"The total number of lymph nodes tested for the presence of cancer.","valueType":"integer"}}],["primary_diagnosis.presenting_symptoms",{"left":{"name":"presenting_symptoms","description":"Indicate presenting symptoms at time of primary diagnosis.","valueType":"string","restrictions":{"codeList":["Abdominal Pain","Anemia","Back Pain","Bloating","Cholangitis","Constipation","Dark Urine","Decreased Appetite","Diabetes","Diarrhea","Fatigue","Fever","Hypoglycemia","Jaundice","Nausea","None","Pale Stools","Pancreatitis","Pruritus/Itchiness","Steatorrhea","Unknown","Vomiting","Weight Loss"]}},"diff":{"name":"presenting_symptoms","description":"Indicate presenting symptoms at time of primary diagnosis.","valueType":"string","restrictions":{"codeList":["Abdominal Pain","Anemia","Back Pain","Bloating","Cholangitis","Constipation","Dark Urine","Decreased Appetite","Diabetes","Diarrhea","Fatigue","Fever","Hypoglycemia","Jaundice","Nausea","None","Pale Stools","Pancreatitis","Pruritus/Itchiness","Steatorrhea","Unknown","Vomiting","Weight Loss"]}}}],["primary_diagnosis.menopause_status",{"left":{"name":"menopause_status","description":"Indicate the menopause status of the patient at the time of primary diagnosis.","valueType":"string","restrictions":{"codeList":["Perimenopausal","Postmenopausal","Premenopausal","Unknown"]}},"diff":{"name":"menopause_status","description":"Indicate the menopause status of the patient at the time of primary diagnosis.","valueType":"string","restrictions":{"codeList":["Perimenopausal","Postmenopausal","Premenopausal","Unknown"]}}}],["specimen.acquisition_interval",{"left":{"name":"acquisition_interval","description":"Interval between primary diagnosis and specimen acquisition, in days.","valueType":"integer","restrictions":{"required":true},"meta":{"units":"days"}},"diff":{"name":"acquisition_interval","description":"Interval between primary diagnosis and specimen acquisition, in days.","valueType":"integer","restrictions":{"required":true},"meta":{"units":"days"}}}],["specimen.pathological_stage_group",{"left":{"name":"pathological_stage_group","description":"Specify the tumour stage, based on tumor_staging_system, used to assess the cancer at the time the tumour specimen was resected.","valueType":"string","restrictions":{"required":true}},"diff":{"name":"pathological_stage_group","description":"Specify the tumour stage, based on tumor_staging_system, used to assess the cancer at the time the tumour specimen was resected.","valueType":"string","restrictions":{"required":true}}}],["specimen.pathological_n_category",{"left":{"name":"pathological_n_category","description":"The code to represent the stage of cancer defined by whether or not the cancer has reached nearby lymph nodes (N), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"},"right":{"name":"pathological_n_category","description":"The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"},"diff":{"description":"The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual."}}],["specimen.pathological_m_category",{"left":{"name":"pathological_m_category","description":"The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"},"diff":{"name":"pathological_m_category","description":"The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","valueType":"string"}}],["registration.program_id",{"right":{"name":"program_id","valueType":"string","description":"Unique identifier of the ARGO program.","restrictions":{"required":true}},"diff":{"name":"program_id","valueType":"string","description":"Unique identifier of the ARGO program.","restrictions":{"required":true}}}],["registration.submitter_donor_id",{"right":{"name":"submitter_donor_id","valueType":"string","description":"Unique identifier of the donor, assigned by the data provider.","restrictions":{"required":true}},"diff":{"name":"submitter_donor_id","valueType":"string","description":"Unique identifier of the donor, assigned by the data provider.","restrictions":{"required":true}}}],["registration.gender",{"right":{"name":"gender","valueType":"string","description":"Description of the donor self-reported gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles.","restrictions":{"required":true,"codeList":["Male","Female","Other"]}},"diff":{"name":"gender","valueType":"string","description":"Description of the donor self-reported gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles.","restrictions":{"required":true,"codeList":["Male","Female","Other"]}}}],["registration.submitter_specimen_id",{"right":{"name":"submitter_specimen_id","valueType":"string","description":"Unique identifier of the specimen, assigned by the data provider.","restrictions":{"required":true}},"diff":{"name":"submitter_specimen_id","valueType":"string","description":"Unique identifier of the specimen, assigned by the data provider.","restrictions":{"required":true}}}],["registration.specimen_type",{"right":{"name":"specimen_type","valueType":"string","description":"Tissue source of the biospecimen.","restrictions":{"required":true,"codeList":["Blood derived","Blood derived - bone marrow","Blood derived - peripheral blood","Bone marrow","Buccal cell","Lymph node","Solid tissue","Plasma","Serum","Urine","Cerebrospinal fluid","Sputum","NOS (Not otherwise specified)","Other","FFPE","Pleural effusion","Mononuclear cells from bone marrow","Saliva","Skin"]}},"diff":{"name":"specimen_type","valueType":"string","description":"Tissue source of the biospecimen.","restrictions":{"required":true,"codeList":["Blood derived","Blood derived - bone marrow","Blood derived - peripheral blood","Bone marrow","Buccal cell","Lymph node","Solid tissue","Plasma","Serum","Urine","Cerebrospinal fluid","Sputum","NOS (Not otherwise specified)","Other","FFPE","Pleural effusion","Mononuclear cells from bone marrow","Saliva","Skin"]}}}],["registration.tumour_normal_designation",{"right":{"name":"tumour_normal_designation","valueType":"string","description":"Description of the kind of tissue that was collected with respect to disease status.","restrictions":{"required":true,"codeList":["Normal","Normal - tissue adjacent to primary tumour","Primary tumour","Primary tumour - adjacent to normal","Primary tumour - additional new primary","Recurrent tumour","Metastatic tumour","Metastatic tumour - metastasis local to lymph node","Metastatic tumour - metastasis to distant location","Metastatic tumour - additional metastatic","Xenograft - derived from primary tumour","Xenograft - derived from tumour cell line","Cell line - derived from xenograft tissue","Cell line - derived from tumour","Cell line - derived from normal"]}},"diff":{"name":"tumour_normal_designation","valueType":"string","description":"Description of the kind of tissue that was collected with respect to disease status.","restrictions":{"required":true,"codeList":["Normal","Normal - tissue adjacent to primary tumour","Primary tumour","Primary tumour - adjacent to normal","Primary tumour - additional new primary","Recurrent tumour","Metastatic tumour","Metastatic tumour - metastasis local to lymph node","Metastatic tumour - metastasis to distant location","Metastatic tumour - additional metastatic","Xenograft - derived from primary tumour","Xenograft - derived from tumour cell line","Cell line - derived from xenograft tissue","Cell line - derived from tumour","Cell line - derived from normal"]}}}],["registration.submitter_sample_id",{"right":{"name":"submitter_sample_id","valueType":"string","description":"Unique identifier of the sample, assigned by the data provider.","restrictions":{"required":true}},"diff":{"name":"submitter_sample_id","valueType":"string","description":"Unique identifier of the sample, assigned by the data provider.","restrictions":{"required":true}}}],["registration.sample_type",{"right":{"name":"sample_type","valueType":"string","description":"Description of the type of molecular sample used for testing.","restrictions":{"required":true,"codeList":["Total DNA","Amplified DNA","ctDNA","Other DNA enrichments","Total RNA","Ribo-Zero RNA","polyA+ RNA","Other RNA fractions"]}},"diff":{"name":"sample_type","valueType":"string","description":"Description of the type of molecular sample used for testing.","restrictions":{"required":true,"codeList":["Total DNA","Amplified DNA","ctDNA","Other DNA enrichments","Total RNA","Ribo-Zero RNA","polyA+ RNA","Other RNA fractions"]}}}],["donor.program_id",{"right":{"description":"Unique identifier of the ARGO program.","name":"program_id","restrictions":{"required":true},"valueType":"string"},"diff":{"description":"Unique identifier of the ARGO program.","name":"program_id","restrictions":{"required":true},"valueType":"string"}}],["specimen.aquistion_interval",{"right":{"name":"aquistion_interval","description":"Interval between primary diagnosis and specimen acquisition, in days.","valueType":"integer","restrictions":{"required":true},"meta":{"units":"days"}},"diff":{"name":"aquistion_interval","description":"Interval between primary diagnosis and specimen acquisition, in days.","valueType":"integer","restrictions":{"required":true},"meta":{"units":"days"}}}],["sample_registration.specimen_submitter_id",{"right":{"name":"specimen_submitter_id","valueType":"string","description":"Unique identifier of the specimen, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}},"diff":{"name":"specimen_submitter_id","valueType":"string","description":"Unique identifier of the specimen, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}}}],["sample_registration.sample_submitter_id",{"right":{"name":"sample_submitter_id","valueType":"string","description":"Unique identifier of the sample, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}},"diff":{"name":"sample_submitter_id","valueType":"string","description":"Unique identifier of the sample, assigned by the data provider.","restrictions":{"required":true,"regex":"[A-Za-z0-9\\-\\._]{1,64}"}}}]]